Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors
Zhihe Liu, Hongqiong Fan, Yuying Li, Chunshui Liu Department of Hematology, Cancer Center, The First Hospital of Jilin University, Changchun, People’s Republic of China Abstract: The aim of this study was to investigate the clinical characteristics and efficacy of chronic myeloid leukemi...
Main Authors: | Liu Z, Fan H, Li Y, Liu C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-07-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/analysis-of-clinical-characteristics-and-efficacy-of-chronic-myeloid-l-peer-reviewed-article-OTT |
Similar Items
-
Screening for an underlying myeloproliferative neoplasm in patients with thrombocytosis post-induction chemotherapy for acute myeloid leukemia
by: Stephen E. Langabeer
Published: (2020-01-01) -
Chronic Myeloid Leukemia: Role of Allogeneic Hematopoietic Stem Cell Transplantation in the Era of Tyrosine Kinase Inhibitors
by: EV Morozova, et al.
Published: (2019-03-01) -
Tyrosine Kinase Inhibitors Available for Chronic Myeloid Leukemia: Efficacy and Safety
by: Valentín García-Gutiérrez, et al.
Published: (2019-07-01) -
Hodgkin Lymphoma in a Case of Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors
by: Smeeta GAJENDRA, et al.
Published: (2019-01-01) -
Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia
by: E. G. Lomaia, et al.
Published: (2014-07-01)